Literature DB >> 21552805

Va-es-bj - an epithelioid sarcoma cell-line.

C Helson1, M Melamed, S Braverman, F Traganos, R Preti, L Helson.   

Abstract

A tumor cell line was derived and established from a bone marrow aspirate of a 41-year-old male who presented with motor symptoms of cord compression and an epidural tumor with osseous, pulmonary and hepatic metastases. The epidural tumor was an epithelioid sarcoma staining positive for cytokeratin markers of epithelial differentiation AE-1 and AE-3. This cell line was composed of lowly refractile, multinucleated giant or mononuclear round or elongated cells with monopolar or bipolar short processes. When permitted to grow beyond confluence these cells clumped up and formed mounds progressing to free floating spheroids. The cells were characterized by chromosomal triploidy with marker chromosomes, rapid growth in nude mice and secretion of immunoreactive and biologically functional granulocyte macrophage colony stimulating factor. This epithelioid sarcoma cell line stained positive for AE-1, AE-3, vimentin, epithelial membrane antigen and was designated VA-ES-BJ.

Entities:  

Year:  1995        PMID: 21552805     DOI: 10.3892/ijo.7.1.51

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology.

Authors:  Samuel V Rasmussen; Jia Xiang Jin; Lissett R Bickford; Andrew D Woods; Felix Sahm; Kenneth A Crawford; Kiyo Nagamori; Hiroaki Goto; Keila E Torres; Angelo Sidoni; Erin R Rudzinski; Khin Thway; Robin L Jones; Alessio Ciulli; Hollis Wright; Melvin Lathara; Ganapati Srinivasa; Kavya Kannan; Paul H Huang; Thomas G P Grünewald; Noah E Berlow; Charles Keller
Journal:  Clin Transl Med       Date:  2022-07

Review 2.  Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy.

Authors:  Jonathan Noujaim; Khin Thway; Zia Bajwa; Ayeza Bajwa; Robert G Maki; Robin L Jones; Charles Keller
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

3.  A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo.

Authors:  Yoshinori Imura; Norifumi Naka; Hidetatsu Outani; Hirohiko Yasui; Satoshi Takenaka; Ken-ichiro Hamada; Ritsuro Ozaki; Mitsunori Kaya; Ken-ichi Yoshida; Eiichi Morii; Akira Myoui; Hideki Yoshikawa
Journal:  BMC Res Notes       Date:  2013-08-01

4.  High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.

Authors:  Makoto Emori; Tomohide Tsukahara; Masaki Murase; Masanobu Kano; Kenji Murata; Akari Takahashi; Terufumi Kubo; Hiroko Asanuma; Kazuyo Yasuda; Vitaly Kochin; Mitsunori Kaya; Satoshi Nagoya; Jun Nishio; Hiroshi Iwasaki; Tomoko Sonoda; Tadashi Hasegawa; Toshihiko Torigoe; Takuro Wada; Toshihiko Yamashita; Noriyuki Sato
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

5.  Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma.

Authors:  Yoshinori Imura; Hirohiko Yasui; Hidetatsu Outani; Toru Wakamatsu; Kenichiro Hamada; Takaaki Nakai; Shutaro Yamada; Akira Myoui; Nobuhito Araki; Takafumi Ueda; Kazuyuki Itoh; Hideki Yoshikawa; Norifumi Naka
Journal:  Mol Cancer       Date:  2014-08-07       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.